13F

Stock

RedHill Biopharma Ltd.

RDHL · held by 17 managers

Reported value

$514.5K

Holders

17

+0 new · −0 exited

Holders’ est. mark

−$347

Price effect on 2 books still in the name

Largest holder

$398.2K

Yorkville Advisors Global, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Yorkville Advisors Global, LP386.6K$398.2KHeld
GAGNON SECURITIES LLC86.1K$88.7KHeld
Citadel15.5K$15.9KHeld
GAMMA Investing LLC4.83K$4.97KHeld
Federation des caisses Desjardins du Quebec3.39K$3.49KHeld
RHUMBLINE ADVISERS2.68K$2.75KHeld
BANK OF AMERICA CORP /DE/303$312−$346Cut−$346
EverSource Wealth Advisors, LLC38$39Held
Your Advocates Ltd., LLP19$20Held
UBS Group AG18$18Held
Garton & Associates Financial Advisors LLC15$15Held
Smartleaf Asset Management LLC5$5Held
SBI Securities Co., Ltd.4$4Held
GROUP ONE TRADING LLC4$4Held
Vermillion Wealth Management, Inc.2$2Held
MORGAN STANLEY1$1−$1Cut−$1
ROYAL BANK OF CANADA1$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.